La mesure concerne la protection des brevets ainsi que la question des modifications progressives là où certaines échappatoires permettent de prolonger la protection accordée par brevet à certains médicaments, qui coûtent alors nettement plus cher aux Canadiens, non seulement aux particuliers, mais également aux régimes d'avantages sociaux d'employés et aux organisations qui dispensent ces médicaments partout au pays.
It deals with patent protection and also the issue of evergreening where legal loopholes extend the patent protection of certain drugs that then cost Canadians significant sums of money, not only to individuals but also in employment benefit plans as well as the organizations that actually provide that across the country.